Inventor
MUHS ANDREAS
CH41 patents
⚠️ This page may combine multiple inventors who share the name “MUHS ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AC IMMUNE SA
15 patentsUS7892544B2Feb 22, 2011
Humanized anti-beta-amyloid antibody
AC IMMUNE SA55 citations97
US7772375B2Aug 10, 2010
Monoclonal antibodies that recognize epitopes of amyloid-beta
AC IMMUNE SA51 citations93
US9585956B2Mar 7, 2017
Polynucleotides encoding anti-amyloid beta monoclonal antibodies
AC IMMUNE SA8 citations84
US9175094B2Nov 3, 2015
Monoclonal antibody
AC IMMUNE SA9 citations84
US8048420B2Nov 1, 2011
Monoclonal antibody
AC IMMUNE SA12 citations84
US10836817B2Nov 17, 2020
Anti-Tau antibodies and methods of use
AC IMMUNE SA10 citations78
US10066010B2Sep 4, 2018
Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau
AC IMMUNE SA4 citations72
US9701660B2Jul 11, 2017
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
AC IMMUNE SA2 citations72
US9657091B2May 23, 2017
Humanized tau antibody
AC IMMUNE SA5 citations72
US9540434B2Jan 10, 2017
Phosphospecific antibodies recognising tau
AC IMMUNE SA5 citations72
US9598485B2Mar 21, 2017
Anti-tau antibodies and methods of use
AC IMMUNE SA4 citations71
US11684576B2Jun 27, 2023
Method of safe administration of phosphorylated tau peptide vaccine
AC IMMUNE SA2 citations69
US12324855B2Jun 10, 2025
Method of safe administration of phosphorylated Tau peptide vaccine
AC IMMUNE SA0 citations59
US10500207B2Dec 10, 2019
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
AC IMMUNE SA1 citations59
US11352419B2Jun 7, 2022
Anti-tau antibodies and methods of use
AC IMMUNE SA0 citations57
PFEIFER ANDREA
9 patentsUS8796439B2Aug 5, 2014
Nucleic acid molecules encoding a humanized antibody
PFEIFER ANDREA15 citations92
US8246954B2Aug 21, 2012
Methods of treating amyloidosis with humanized anti-beta-amyloid antibodies
PFEIFER ANDREA24 citations92
US8124353B2Feb 28, 2012
Methods of treating and monitoring disease with antibodies
PFEIFER ANDREA20 citations92
US9146244B2Sep 29, 2015
Polynucleotides encoding an anti-beta-amyloid monoclonal antibody
PFEIFER ANDREA6 citations84
US9403902B2Aug 2, 2016
Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody
PFEIFER ANDREA7 citations83
US9304138B2Apr 5, 2016
Pharmaceutical composition
PFEIFER ANDREA12 citations83
US8647631B2Feb 11, 2014
Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines
PFEIFER ANDREA16 citations83
US8613923B2Dec 24, 2013
Monoclonal antibody
PFEIFER ANDREA7 citations83
US9221900B2Dec 29, 2015
Methods for identifying safe and functional humanized antibodies
PFEIFER ANDREA3 citations62
WEIDMUELLER INTERFACE
4 patentsUSD613246SApr 6, 2010
Connector
WEIDMUELLER INTERFACE44 citations89
US7367832B2May 6, 2008
Adapter for attaching an insertion device to a cable fitting
WEIDMUELLER INTERFACE33 citations89
US7670060B2Mar 2, 2010
Plug connector with an adaptor housing for receiving a plug or socket arrangement
WEIDMUELLER INTERFACE11 citations83
US7369059B2May 6, 2008
Electrical apparatus having status indicating means
WEIDMUELLER INTERFACE4 citations59
JANSSEN PHARMACEUTICALS INC
3 patentsUS11124552B2Sep 21, 2021
Compositions of phosphorylated tau peptides and uses thereof
JANSSEN PHARMACEUTICALS INC8 citations80
US11591377B2Feb 28, 2023
Heterologous administration of tau vaccines
JANSSEN PHARMACEUTICALS INC2 citations70
US11958889B2Apr 16, 2024
Compositions of phosphorylated tau peptides and uses thereof
JANSSEN PHARMACEUTICALS INC0 citations59
KROTH HEIKO
2 patentsUS9221812B2Dec 29, 2015
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
KROTH HEIKO15 citations79
US8916590B2Dec 23, 2014
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
KROTH HEIKO2 citations61